Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RINNOPARI: Cohort for Chronic Inflammatory Respiratory Diseases
NCT02924818Recruiting
- Sponsor
- CHU de Reims
- Start
- Nov 2016
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Open-label trial (5 cohorts), sponsored by CHU de Reims. Primary endpoint: Cytokines (Th1, Th2, Th17, Tc1, Tc2, Tc17) measurements in blood sample at 10 years. Started Nov 2016; status: recruiting.
Beyond the preview
Go deeper on NCT02924818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924818.